CCL2 and breast carcinoma: High levels of CCL2 expression in various types of tumors are also associated with poor prognosis (Yang et al., 2016); for example, the increased level of CCL2 expression is related to poor prognosis in breast cancer patients (Lebrecht et al., 2004; Fang et al., 2015).